A genomic-based healthcare business that profiles gut microbes to help people take charge of their wellbeing has been identified as one of Australia’s top start-ups by a leading global accelerator program.
Microba, which is in the early stages of development at UQ’s ilab innovation incubator, was named in the top five potential start-ups at the Bridge to MassChallenge Australia competition.
UQ researcher and Microba co-founder Professor Gene Tyson said Microba would provide people with comprehensive analyses of microorganisms in their gut, including information on function and key microbes important for health.
“Our success in the Bridge to MassChallenge Australia competition recognises that we’re developing a great healthcare tool to take to market, and that we’re also on the right path from a business perspective during the critical development and growth stages,” Professor Tyson said.
Director of ilab Bernie Woodcroft said the US-based MassChallenge was one of the world’s top accelerators, with an international track record of helping start-ups grow.
“Microba was selected from a pool of 200 entries, with co-founder Dr Alena Rinke travelling to Boston in the US to participate in a five-day MassChallenge boot camp comprising training, mentorship and access to the city’s start-up and investment ecosystem.”
Microba is developing its business through ilab at UQ’s intensive three-month Germinate Program, which helps future entrepreneurs develop their diverse business start-up ideas.
More than 130 start-up companies and their founders have been supported by ilab since 2012, and more than $17 million in early stage capital has been raised in the past two years.